U
BSX icon

UBS’s Boston Scientific BSX Stock Holding History

UBS’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.46M Buy
123,800
+8,000
+7% +$101K ﹤0.01% 3208
2014
Q2 		$1.48M Buy
115,800
+1,200
+1% +$15.6K ﹤0.01% 3183
2014
Q1 		$1.55M Buy
114,600
+35,700
+45% +$469K ﹤0.01% 3034
2013
Q4 		$948K Sell
78,900
-77,600
-50% -$917K ﹤0.01% 3606
2013
Q3 		$1.84M Buy
156,500
+131,200
+519% +$1.42M ﹤0.01% 2682
2013
Q2 		$235K Buy
+25,300
New +$215K ﹤0.01% 4919

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

UBS's BSX Position: Q3 2014 in Review

UBS increased its Boston Scientific (BSX) stake by 7.9% in Q3 2014, buying an estimated $1.48M and bringing the position to 1,610,474 shares worth $19M. The position accounts for 0.01% of the portfolio, ranked #985.

UBS first reported a position in BSX in Q2 2013 and has held it in 6 quarters since. The position peaked at $20.1M in Q1 2014. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

  • UBS held 1,610,474 shares of Boston Scientific worth $19M as of Q3 2014.
  • UBS bought 117,514 Boston Scientific shares in Q3 2014, an estimated $1.48M.
  • Boston Scientific made up 0.01% of UBS's portfolio in Q3 2014, its #985 holding.
  • UBS first reported a position in Boston Scientific in Q2 2013 and has held it in 6 quarters since.
  • UBS's Boston Scientific position peaked at $20.1M in Q1 2014.
  • 437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.